Polpharma Biologics Integrates Bioceros

Company Plans To Retire The Bioceros Name Thereafter

Integration
Polpharma Biologics has fully integrated Bioceros and its proprietary cell line development platform • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business